Cardinal Health (CAH) posts earnings beat on $254.2B revenue, 14.2% YoY growth
Cardinal Health’s headline earnings beat comes with a more complicated underlying picture, as the distributor operates on $254.2B of revenue but only a 0.7% net margin. The setup leaves CAH’s upside dependent on the durability of earnings growth rather than the beat alone.
STOCK PHOTO · TOWFIQU BARBHUIYAThe story
Cardinal Health reported a large earnings beat alongside fiscal-year revenue of $254.2B for the year ended June 30, 2026, up 14.2% year over year, with diluted EPS of $7.23. That scale has not translated into substantial profitability: gross margin was 3.8% and net margin was 0.7%. The figures frame the core mechanism behind the more complicated read—small changes in operating performance can matter disproportionately when margins are so thin, even as strong revenue growth supports the earnings base. The next read-through depends on the composition of the beat, forward guidance, and evidence that profitability is improving rather than merely tracking higher volume.
Our read · Wed, Aug 19
The earnings beat is mixed for CAH: $254.2B of revenue and 14.2% YoY growth support the top line, but 0.7% net margins leave the durability of the upside unproven.
Why. The trade hinges on margin durability, not the beat headline: CAH’s $254.2B revenue base grew 14.2% YoY, but a 0.7% net margin leaves limited room for execution slippage. Without the beat magnitude or forward guidance in the supplied report, the evidence supports a watchful, two-sided setup rather than a firm single-name lean.
Both cases
What could change this view: A weaker-than-expected margin trajectory or cautious forward guidance would undermine the earnings-growth read; sustained margin improvement would invalidate the cautious setup.
Who reported it · 1
Keep reading
More on CAH
Cardinal Health raises fiscal 2027 outlook after $67.5B quarterLatest on the Wire
Trump threatens overseas AI data-centre ban for US firmsBitcoin drops below $59,000 as cash rush revives summer-low testGreer says US chip curbs will close China export-control loopholesBlackRock bitcoin ETF posts $541.1 million outflow as tech sell-off spreadsPoland says Russian missiles and drone crashed during Ukraine assaultContinue on the Wire →Latest on the Wire
Anthropic debut fails to halt technology-led slide in US stocksUS MATCH Act puts ASML at center of China chip export disputeBeijing plans to bar young red-chip firms from overseas listingsGerman producer prices jump 8.1% in October as industrial inflation acceleratesContinue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangAnthropic IPO could become the largest in US history on ThursdayAbout this report
Reported by Yahoo Finance as Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story
, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →